{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/leg-ulcer-venous/","result":{"data":{"firstChapter":{"id":"01818c5e-efb9-59c4-b339-08b834294232","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field 131effa5-f0f8-417c-a344-5df95e6a17a3 --><h1>Leg ulcer - venous: Summary</h1><!-- end field 131effa5-f0f8-417c-a344-5df95e6a17a3 -->","htmlStringContent":"<!-- begin item f9302b37-44e1-458d-8935-5e00d7171c75 --><!-- begin field 8af28de8-e3be-49be-a39f-0686156de870 --><ul><li>​​​​​​A leg ulcer is a break in the skin below the knee which has not healed within 2 weeks.</li><li>A venous leg ulcer occurs in the presence of venous disease and is the most common type of leg ulcer, accounting for 60–80% of cases. It typically occurs in the gaiter area of the leg (from the ankle to mid-calf).<ul><li>Other causes of leg ulceration and/or delayed wound healing include arterial disease, diabetes, rheumatoid arthritis, vasculitis, sickle cell disease, malignancy, and drugs (such as nicorandil, corticosteroids, and nonsteroidal anti-inflammatory drugs).</li></ul></li><li>Venous leg ulceration is caused by sustained venous hypertension, which results from chronic venous insufficiency due to venous valve incompetence or an impaired calf muscle pump.</li><li>Risk factors include obesity, immobility, increasing age, varicose veins, and a history of deep vein thrombosis (DVT). </li><li>The estimated prevalence of venous leg ulcers in the UK is between 0.1–0.3%, and this increases with age. </li><li>Complications include chronic pain, infection, contact dermatitis (caused by allergens in creams and dressings), and negative impacts on quality of life and daily functioning.</li><li>There is a wide variation in published healing and recurrence rates of venous leg ulcers:<ul><li>Six-month healing rates have been reported as 45% for people treated in the community, and 70% for people treated in specialist clinics.</li><li>Twelve-month recurrence rates range between 26–69%. </li><li>Repeat cycles of ulceration, healing, and recurrence are common.</li></ul></li><li>Assessment of a person with a venous leg ulcer should include: <ul><li>Asking about the symptoms experienced (type, duration, and severity).</li><li>Identifying risk factors, such as immobility and a history of DVT. </li><li>Examining the wound (site, edge, size, depth, wound bed, and for signs of infection). </li><li>Examining the legs (for oedema, varicose veins, venous skin changes, and reduced ankle mobility). </li><li>Assessing for other causes of ulceration and/or delayed wound healing.</li><li>Measuring the ankle-brachial pressure index in both legs to exclude arterial insufficiency.</li></ul></li><li>Primary care management includes: <ul><li>Cleaning and dressing the wound. </li><li>Starting compression therapy if appropriate. </li><li>Considering prescribing pentoxifylline to increase microcirculatory blood flow and improve ulcer healing.</li><li>Managing associated conditions, such as oedema and venous eczema.</li><li>Managing complications, such as pain and infection.</li><li>Providing information and lifestyle advice to promote ulcer healing and reduce the risk of recurrence, for example encouraging compliance with compression therapy, keeping mobile with regular walking (to exercise calf muscle pump function), elevating legs when immobile, avoiding leg trauma, and using emollient frequently. </li><li>Arranging follow up to reassess the ulcer. </li><li>Arranging specialist referral where appropriate, for example if there is an uncertain diagnosis or a suspected alternative cause of ulceration, or if there is delayed or no healing after 2 weeks of adequate treatment.</li></ul></li><li>To reduce the risk of recurrence after the leg ulcer has healed:<ul><li>Long-term use of below-knee graduated compression hosiery is recommended.</li><li>Lifestyle measures should be encouraged.</li><li>The person should be reviewed appropriately.</li></ul></li></ul><!-- end field 8af28de8-e3be-49be-a39f-0686156de870 --><!-- end item f9302b37-44e1-458d-8935-5e00d7171c75 -->","topic":{"id":"627b2b3c-014b-5543-8f89-0f3ffa6344ad","topicId":"4c5db985-9544-48b2-8c54-8915ec210739","topicName":"Leg ulcer - venous","slug":"leg-ulcer-venous","aliases":[],"chapters":[{"id":"01818c5e-efb9-59c4-b339-08b834294232","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"313e84c5-8bc7-5150-826a-467ea7252acd","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"2597db24-8ec5-54d4-86ad-8082be50f4f6","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"38f24092-0019-582d-86bf-d1f61bccde1d","slug":"changes","fullItemName":"Changes"},{"id":"cdc15e74-0503-53a5-a4be-c53ec4e20898","slug":"update","fullItemName":"Update"}]},{"id":"73d0cf59-f9c0-5785-8c74-e756826d5d1e","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"64b11689-d52a-560f-8d9b-c592d654615e","slug":"goals","fullItemName":"Goals"},{"id":"ac3d1637-467f-5edb-8fd8-73f66160080f","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"4bffe5b2-0ce0-5ae8-8c0b-914bb6ed5a1d","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"82441da5-60f5-53b4-b510-187f7bacb4a8","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"3e5817d5-30e7-54b7-b9ba-224b4a295bba","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"b30bb006-efbc-5a69-90f3-30abf232a97d","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"84dc0da0-8533-5c5d-99f6-7c04a116701a","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"45d8d35d-9757-544c-b04e-9747898a1f0e","slug":"definition","fullItemName":"Definition"},{"id":"21acb832-e5e8-5bd1-9b8d-9410ec5011bf","slug":"causes-risk-factors","fullItemName":"Causes and risk factors"},{"id":"cf27bd7b-b787-5def-bb40-ee0f134a8aca","slug":"prevalence","fullItemName":"Prevalence"},{"id":"a55a1739-f3d2-534c-b533-f6406d9c81ea","slug":"complications","fullItemName":"Complications"},{"id":"683b612a-3f1d-5580-951b-e14672f52b4a","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"dbc94220-a914-56d0-883d-d158da511e1c","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"57b3b7a5-9042-53fa-a236-56d0d02b647e","slug":"assessment","fullItemName":"Assessment"},{"id":"35ee8784-602e-5a29-9ccf-65b3c3f940d2","slug":"interpretation-of-abpi","fullItemName":"Interpretation of ABPI"},{"id":"0c766f2c-0c8f-521b-85fd-e947ba6b2d09","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"5e199f8a-7621-5318-9da1-264db8f544b8","slug":"management","fullItemName":"Management","subChapters":[{"id":"c8bda10b-ebb6-533b-9c91-96efa5ddf0c3","slug":"venous-leg-ulcers","fullItemName":"Scenario: Venous leg ulcers"}]},{"id":"e084faba-a409-53ac-aa53-08b80a3991f1","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"66a7f656-c6f5-57a2-a08a-1533a6fd4e92","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"a6cda703-9039-5115-b3d3-478cdb4d1e55","slug":"co-amoxiclav","fullItemName":"Co-amoxiclav"},{"id":"1cf75cbb-8bc4-58cc-9a1b-11516db5ad2c","slug":"co-trimoxazole","fullItemName":"Co-trimoxazole"},{"id":"3f0efc32-779b-56f6-85ca-e46a59745bed","slug":"doxycycline","fullItemName":"Doxycycline"},{"id":"fe306aab-d8d7-5181-a461-128f2aa3c65a","slug":"erythromycin","fullItemName":"Erythromycin"},{"id":"314a80d5-e16b-5625-8d64-4141535ff392","slug":"flucloxacillin","fullItemName":"Flucloxacillin"},{"id":"b7e7b8ec-799c-5ea5-9ac0-11935f899b8a","slug":"oral-analgesia","fullItemName":"Oral analgesia"},{"id":"43ed3b03-6322-5690-8f85-b6e10a0b3d3e","slug":"pentoxifylline","fullItemName":"Pentoxifylline"}]},{"id":"19f3ffbe-f365-5196-8586-0dceeaf69908","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"89207239-b8a4-50ce-8b2d-3065a830c0af","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"45831e7c-0e6f-50f3-a513-fe4fcacff65e","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"3d90cdb0-b2fd-5bfd-bd2d-342e36901f9d","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"8b66d1a4-6ee5-5556-b671-204219a81787","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"5b8ee442-8da6-524f-bf34-e6a9cc2a771e","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"6fa96be3-beae-51f6-9f1c-4d278b058d09","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"e75dc366-237b-55d2-a654-2e3bf503b955","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"627b2b3c-014b-5543-8f89-0f3ffa6344ad","topicId":"4c5db985-9544-48b2-8c54-8915ec210739","topicName":"Leg ulcer - venous","slug":"leg-ulcer-venous","aliases":[],"topicSummary":"A leg ulcer is defined as the loss of skin below the knee on the leg or foot, which takes more than 2 weeks to heal.","lastRevised":"Last revised in January 2021","nextPlannedReviewBy":"2024-08-01T00:00:00+01:00","nextPlannedReviewByDateTime":"2024-07","nextPlannedReviewByDisplay":"July 2024","specialities":[{"id":"50071c38-ab10-5ab8-ac70-6bd19a96c24e","name":"Skin and nail","slug":"skin-nail"}],"chapters":[{"id":"01818c5e-efb9-59c4-b339-08b834294232","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"313e84c5-8bc7-5150-826a-467ea7252acd","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"2597db24-8ec5-54d4-86ad-8082be50f4f6","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"38f24092-0019-582d-86bf-d1f61bccde1d","slug":"changes","fullItemName":"Changes"},{"id":"cdc15e74-0503-53a5-a4be-c53ec4e20898","slug":"update","fullItemName":"Update"}]},{"id":"73d0cf59-f9c0-5785-8c74-e756826d5d1e","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"64b11689-d52a-560f-8d9b-c592d654615e","slug":"goals","fullItemName":"Goals"},{"id":"ac3d1637-467f-5edb-8fd8-73f66160080f","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"4bffe5b2-0ce0-5ae8-8c0b-914bb6ed5a1d","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"82441da5-60f5-53b4-b510-187f7bacb4a8","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"3e5817d5-30e7-54b7-b9ba-224b4a295bba","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"b30bb006-efbc-5a69-90f3-30abf232a97d","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"84dc0da0-8533-5c5d-99f6-7c04a116701a","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"45d8d35d-9757-544c-b04e-9747898a1f0e","slug":"definition","fullItemName":"Definition"},{"id":"21acb832-e5e8-5bd1-9b8d-9410ec5011bf","slug":"causes-risk-factors","fullItemName":"Causes and risk factors"},{"id":"cf27bd7b-b787-5def-bb40-ee0f134a8aca","slug":"prevalence","fullItemName":"Prevalence"},{"id":"a55a1739-f3d2-534c-b533-f6406d9c81ea","slug":"complications","fullItemName":"Complications"},{"id":"683b612a-3f1d-5580-951b-e14672f52b4a","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"dbc94220-a914-56d0-883d-d158da511e1c","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"57b3b7a5-9042-53fa-a236-56d0d02b647e","slug":"assessment","fullItemName":"Assessment"},{"id":"35ee8784-602e-5a29-9ccf-65b3c3f940d2","slug":"interpretation-of-abpi","fullItemName":"Interpretation of ABPI"},{"id":"0c766f2c-0c8f-521b-85fd-e947ba6b2d09","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"5e199f8a-7621-5318-9da1-264db8f544b8","slug":"management","fullItemName":"Management","subChapters":[{"id":"c8bda10b-ebb6-533b-9c91-96efa5ddf0c3","slug":"venous-leg-ulcers","fullItemName":"Scenario: Venous leg ulcers"}]},{"id":"e084faba-a409-53ac-aa53-08b80a3991f1","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"66a7f656-c6f5-57a2-a08a-1533a6fd4e92","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"a6cda703-9039-5115-b3d3-478cdb4d1e55","slug":"co-amoxiclav","fullItemName":"Co-amoxiclav"},{"id":"1cf75cbb-8bc4-58cc-9a1b-11516db5ad2c","slug":"co-trimoxazole","fullItemName":"Co-trimoxazole"},{"id":"3f0efc32-779b-56f6-85ca-e46a59745bed","slug":"doxycycline","fullItemName":"Doxycycline"},{"id":"fe306aab-d8d7-5181-a461-128f2aa3c65a","slug":"erythromycin","fullItemName":"Erythromycin"},{"id":"314a80d5-e16b-5625-8d64-4141535ff392","slug":"flucloxacillin","fullItemName":"Flucloxacillin"},{"id":"b7e7b8ec-799c-5ea5-9ac0-11935f899b8a","slug":"oral-analgesia","fullItemName":"Oral analgesia"},{"id":"43ed3b03-6322-5690-8f85-b6e10a0b3d3e","slug":"pentoxifylline","fullItemName":"Pentoxifylline"}]},{"id":"19f3ffbe-f365-5196-8586-0dceeaf69908","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"89207239-b8a4-50ce-8b2d-3065a830c0af","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"45831e7c-0e6f-50f3-a513-fe4fcacff65e","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"3d90cdb0-b2fd-5bfd-bd2d-342e36901f9d","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"8b66d1a4-6ee5-5556-b671-204219a81787","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"5b8ee442-8da6-524f-bf34-e6a9cc2a771e","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"6fa96be3-beae-51f6-9f1c-4d278b058d09","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"e75dc366-237b-55d2-a654-2e3bf503b955","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"627b2b3c-014b-5543-8f89-0f3ffa6344ad"}},"staticQueryHashes":["3666801979"]}